Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Highlights of the Global Market for GI Therapeutics and Diagnostics
Chapter 2 Market Overview
- Overview of the Gastrointestinal System
- Physiology of the GI System and the Role of Each Part in the GI Process
Chapter 3 Market Dynamics
- Drivers
- Increasing Prevalence of GI Cancer
- Increasing Prevalence of GI Disorders
- Growing Trend toward Screening and Preventive Care
- Growing Adoption and Approval of Biological Drugs
- High Unmet Need
- Challenges
- Loss of Exclusivity and Genericization
- Regulatory and Safety Issues
Chapter 4 Emerging Technologies and Developments
- Overview
- Incorporation of AI and Other Digital Technologies
- Single-Use Endoscopes
- Focus on Biologics
Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Global Market for Prescription GI Therapeutics, by Drug Type
- Anti-inflammatories for Bowel Diseases
- Gastrointestinal Cancer
- Proton Pump Inhibitors
- Anti-diarrheals
- Others
- Global Market for Prescription GI Drugs, by Type
- Anti-inflammatories for Bowel Diseases
- Gastrointestinal Cancer Therapeutics
- Proton Pump Inhibitors
- Anti-diarrheals
- Others
- Trends in the Market for Prescription GI Drugs
- Global Market for Over-the-Counter GI Drugs, by Drug Type
- Laxatives
- Antacids
- Proton Pump Inhibitors
- Histamine-2 Blockers and Inhibitors
- Anti-diarrheals
- Global Market for Over-the-Counter GI Drugs, by Type
- Laxatives
- Antacids
- Proton Pump Inhibitors
- Histimine-2 Blockers
- Anti-diarrheals
- Opportunities in the Market of Over-the-Counter GI Medications
- Global Market for Gastrointestinal Endoscopy Equipment
- GI Endoscopes and Visualization Systems
- GI Endotherapy Devices
- Global Market for GI Endoscopy Equipment, by Product
- Technological Trends in the Market for GI Endoscopy
- Global Market for GI Endoscopy Equipment, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Opportunities in the Market for GI Endoscopy Equipment
- Global Market for GI Vaccines
- Rotavirus Vaccine
- Hepatitis
- Hepatitis Vaccine
- Global Market for GI Vaccines, by Disease Type
- Global Market for Rotavirus Vaccines, by Region
- Global Market for Hepatitis Vaccines by Region
- Geographic Breakdown
- Global Market for GI Therapeutics and Diagnostics, by Region
- Market Revenue, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Intelligence
- Overview
- Over-the-Counter GI Drugs
- Prescription GI Drugs
- GI Endoscopy Equipment
- GI Vaccines
- GI Disease Types
- Disease Types
- Inflammatory Bowel Diseases
- GI Cancer
- Gastroesophageal Reflux Disease
List of Tables
Summary Table: Global Market for GI Therapeutics and Diagnostics, by Product Type, Through 2028
Table 1: Estimated New GI Cancer Cases, by Cancer Site, 2020-2040
Table 2: Common GI Conditions Prevalence
Table 3: First-Time Biosimilar and Generic Approvals for GI Drugs, October 2022-January 2023
Table 4: Artificial Intelligence Applications in GI Disease Diagnostics and Therapeutics
Table 5: Artificial Intelligence-Powered Gastrointestinal Lesion Software Detection System
Table 6: Artificial Intelligence-Related Acquisitions and Collaborations in the GI Drug and Diagnostics Market, 2023
Table 7: Inflammatory Bowel Disease Types
Table 8: Prevalence of Inflammatory Bowel Disease, 2023
Table 9: Selected Anti-inflammatory Prescription Drugs for Inflammatory Bowel Diseases
Table 10: Common GI Cancers, 2020
Table 11: Selected FDA-Approved Drugs for GI Cancer Treatment
Table 12: Selected Prescription Proton Pump Inhibitors
Table 13: Selected Prescription Anti-diarrheals
Table 14: Other Functional Bowel Disorder Agents
Table 15: Global Market for Prescription GI Drugs, by Type, Through 2028
Table 16: Global Market for Anti-inflammatory Drugs for Bowel Disease, by Region, Through 2028
Table 17: Global Market for GI Cancer Therapeutics, by Region, Through 2028
Table 18: Global Market for Prescription Proton Pumpers, by Region, Through 2028
Table 19: Global Market for Prescription Anti-diarrheals, by Region, Through 2028
Table 20: Global Market for Other Types of Prescription GI Drugs, by Region, Through 2028
Table 21: Selected Over-the-Counter Laxatives
Table 22: Selected Over-the-Counter Antacids
Table 23: Selected Over-the-Counter Proton Pump Inhibitors
Table 24: Selected Over-the-Counter Histamine-2 Blockers
Table 25: Over-the-Counter Proton Pump Inhibitors versus Histamine-2 Inhibitors Versus Antacids
Table 26: Over-the-Counter Options Available for Heartburn
Table 27: Selected Over-the-Counter Anti-diarrheals
Table 28: Global Market for Over-the-Counter GI Drugs, by Type, Through 2028
Table 29: Global Market for Laxatives, by Region, Through 2028
Table 30: Global Market for Antacids, by Region, Through 2028
Table 31: Global Market for Over-the-Counter Proton Pump Inhibitors, by Region, Through 2028
Table 32: Global Market for Histimine-2 Inhibitors, by Region, Through 2028
Table 33: Global Market for Over-the-Counter Anti-diarrheals, by Region, Through 2028
Table 34: Therapeutic Uses of GI Endoscopy
Table 35: Selected GI Conditions
Table 36: Global Market for GI Endoscopy Equipment, by Product, Through 2028
Table 37: Commercially Available Capsule Endoscope
Table 38: Global Market for GI Endoscopy Equipment, by Region, Through 2028
Table 39: North American Market for GI Endoscopy Equipment, by Product, Through 2028
Table 40: Selected European Countries Health Spending Per Capita Growth, 2010-2020
Table 41: European Market for GI Endoscopy Equipment, by Product, Through 2028
Table 42: Asia-Pacific Market for GI Endoscopy Equipment, by Product, Through 2028
Table 43: RoW Market for GI Endoscopy Equipment, by Product, Through 2028
Table 44: Rotavirus Vaccines
Table 45: Hepatitis Types
Table 46: Hepatitis Vaccines
Table 47: Global Market for GI Vaccines, by Disease Type, Through 2028
Table 48: Global Market for Rotavirus Vaccines, by Region, Through 2028
Table 49: Global Market for Hepatitis Vaccines, by Region, Through 2028
Table 50: Global Market for GI Therapeutics and Diagnostics, by Region, Through 2028
Table 51: North American Market for GI Therapeutics and Diagnostics, by Product Type, Through 2028
Table 52: European Market for GI Therapeutics and Diagnostics, by Product Type, Through 2028
Table 53: Estimated Population and GI Cancer Cases, by Region, 2020 and 2040
Table 54: Asia-Pacific Market for GI Therapeutics and Diagnostics, by Product Type, Through 2028
Table 55: RoW Market for GI Therapeutics and Diagnostics, by Product Type, Through 2028
Table 56: Global Company Ranking in the Market for Over-the-Counter GI Drugs, 2022
Table 57: Global Company Ranking in the Market for Anti-inflammatory Drugs for Bowel Diseases, 2022
Table 58: Global Company Ranking in the Market for GI Cancer Drugs, 2022
Table 59: Leading Companies in the Number of Phase III Clinical Trials on IBD Drugs
Table 60: Leading Companies in the Number of Phase III Clinical Trials on GI Cancer Drugs
Table 61: Leading Companies in the Number of Phase III Clinical Trials on GERD Drugs
Table 62: Acronyms
Table 63: AbbVie Inc.: Company Snapshot
Table 64: AbbVie Inc.: Financial Performance, FY 2022 and 2023
Table 65: AbbVie Inc.: Product Portfolio
Table 66: Abbvie Inc.: News/Key Developments, 2022-2023
Table 67: Bayer AG: Company Snapshot
Table 68: Bayer AG: Financial Performance, FY 2022 and 2023
Table 69: Bayer AG: Product Portfolio
Table 70: Bayer AG: News/Key Developments, 2023
Table 71: Boston Scientific Corp.: Company Snapshot
Table 72: Boston Scientific Corp.: Financial Performance, FY 2022 and 2023
Table 73: Boston Scientific Corp.: Product Portfolio
Table 74: Boston Scientific Corp.: News/Key Developments, 2023
Table 75: Bristol-Myers Squibb Co.: Company Snapshot
Table 76: Bristol-Myers Squibb Co.: Financial Performance, FY 2022 and 2023
Table 77: Bristol-Myers Squibb Co.: Product Portfolio
Table 78: Bristol-Myers Squibb Co.: News/Key Developments, 2022
Table 79: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 80: F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 81: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 82: F. Hoffmann-La Roche Ltd.: News/Key Developments, 2022 and 2023
Table 83: GSK PLC: Company Snapshot
Table 84: GSK PLC: Financial Performance, FY 2022 and 2023
Table 85: GSK PLC: Product Portfolio
Table 86: Haleon Group of Co.: Company Snapshot
Table 87: Haleon Group of Co.: Financial Performance, FY 2022 and 2023
Table 88: Haleon Group of Co.: Product Portfolio
Table 89: Haleon Group of Co.: News/Key Developments, 2022
Table 90: Johnson & Johnson Services Inc.: Company Snapshot
Table 91: Johnson & Johnson Services Inc.: Financial Performance, FY 2022 and 2023
Table 92: Johnson & Johnson Services Inc.: Product Portfolio
Table 93: Johnson & Johnson Services Inc.: News/Key Developments, 2022 and 2023
Table 94: Olympus Corp.: Company Snapshot
Table 95: Olympus Corp.: Financial Performance, FY 2022 and 2023
Table 96: Olympus Corp.: Product Portfolio
Table 97: Olympus Corp.: News/Key Developments, 2022-2023
Table 98: Procter & Gamble: Company Snapshot
Table 99: Procter & Gamble: Financial Performance, FY 2022 and 2023
Table 100: Procter & Gamble: Product Portfolio
Table 101: Sanofi: Company Snapshot
Table 102: Sanofi: Financial Performance, FY 2022 and 2023
Table 103: Sanofi: Product Portfolio
Table 104: Sanofi: News/Key Developments, 2022-2023
Table 105: Takeda Pharmaceutical Co. Ltd.: Company Snapshot
Table 106: Takeda Pharmaceutical Co. Ltd.: Financial Performance, FY 2021 and 2022
Table 107: Takeda Pharmaceutical Co. Ltd.: Product Portfolio
Table 108: Takeda Pharmaceutical Co. Ltd.: Key Developments, 2022-2023
List of Figures
Summary Figure: Global Market Shares of GI Therapeutics and Diagnostics, by Product Type, 2022
Figure 1: Market Dynamics of Gastrointestinal Therapeutics and Diagnostics
Figure 2: Estimated New GI Cancer Cases, by Cancer Type, 2020-2040
Figure 3: Emerging Trends and Technologies in Gastrointestinal Care
Figure 4: Five-Year Overall Survival Rates in the U.S., by GI Cancer Type, 2022
Figure 5: Global Market Shares of Prescription GI Drugs, by Type, 2022
Figure 6: Trends in the Market for Prescription GI Drugs
Figure 7: Market Drivers in the Market for Over-the-Counter GI Drugs
Figure 8: Global Market for Over-the-Counter GI Drugs, by Type, 2020-2028
Figure 9: Global Market Shares of Over-the-Counter GI Drugs, by Type, 2022
Figure 10: Opportunities in the Market of Over-the-Counter GI Medications
Figure 11: Global Market Shares of GI Endoscopy Equipment, by Product, 2022
Figure 12: Global Market Shares of GI Endoscopy Equipment, by Region, 2022
Figure 13: Opportunities in the Market for GI Endoscopy
Figure 14: Global Market Shares of GI Vaccines, by Disease Type, 2022
Figure 15: Global Market Shares of GI Therapeutics and Diagnostics, by Region, 2022
Figure 16: Estimated Share of GI Cancer Cases, by Region, 2020 and 2040
Figure 17: Global Market Shares of GI Endoscopy Equipment, by Leading Company, 2022
Figure 18: Global Market Shares of GI Vaccines, by Leading Company, 2022
Figure 19: Industry Sponsored Phase II or III Clinical Trials on GI Diseases, by Disease Type, December 2023
Figure 20: AbbVie Inc.: Revenue Share, by Business Unit, FY 2023
Figure 21: AbbVie Inc.: Revenue Share, by Country/Region, FY 2023
Figure 22: Bayer AG: Revenue Share, by Business Unit, FY 2023
Figure 23: Bayer AG: Revenue Share, by Country/Region, FY 2023
Figure 24: Boston Scientific Corp.: Revenue Share, by Business Unit, FY 2023
Figure 25: Boston Scientific Corp.: Revenue Share, by Country/Region, FY 2023
Figure 26: Bristol-Myers Squibb Co.: Revenue Share, by Business Unit, FY 2023
Figure 27: Bristol-Myers Squibb Co.: Revenue Share, by Country/Region, FY 2023
Figure 28: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 29: F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 30: GSK PLC: Revenue Share, by Business Unit, FY 2023
Figure 31: GSK PLC: Revenue Share, by Country/Region, FY 2023
Figure 32: Haleon Group of Co.: Revenue Share, by Business Unit, FY 2023
Figure 33: Haleon Group of Co.: Revenue Share, by Country/Region, FY 2023
Figure 34: Johnson & Johnson Services Inc.: Revenue Share, by Business Unit, FY 2023
Figure 35: Johnson & Johnson Services Inc.: Revenue Share, by Country/Region, FY 2023
Figure 36: Olympus Corp.: Revenue Share, by Business Unit, FY 2023
Figure 37: Olympus Corp.: Revenue Share, by Country/Region, FY 2023
Figure 38: Procter & Gamble: Revenue Share, by Business Unit, FY 2023
Figure 39: Procter & Gamble: Revenue Share, by Country/Region, FY 2023
Figure 40: Sanofi: Revenue Share, by Business Unit, FY 2023
Figure 41: Sanofi: Revenue Share, by Country/ Region, FY 2023
Figure 42: Takeda Pharmaceutical Co. Ltd.: Revenue Shares, by Business Unit, FY 2022
Figure 43: Takeda Pharmaceutical Co. Ltd.: Revenue Shares, by Country/Region, FY 2022
